Bcl-2 related protein A1 Antibody (OTI3D10) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-70246UV
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI3D10
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Bcl-2 related protein A1 Antibody (OTI3D10) [DyLight 350]
Immunogen
Full length recombinant protein of human Bcl-2 related protein A1 (NP_004040) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Bcl-2 related protein A1 Antibody (OTI3D10) [DyLight 350]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Bcl-2 related protein A1
Alternate Names
BCL2A1, Bcl2L5, Bfl-1, GRS
Gene Symbol
BCL2A1
Additional Bcl-2 related protein A1 Products
Product Documents for Bcl-2 related protein A1 Antibody (OTI3D10) [DyLight 350]
Product Specific Notices for Bcl-2 related protein A1 Antibody (OTI3D10) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...